Actuate Therapeutics, Inc. (ACTU)
(Real Time Quote from BATS)
$6.87 USD
-0.20 (-2.83%)
Updated Aug 5, 2025 02:30 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Actuate Therapeutics, Inc. has a market cap of $144.73M, which represents its share price of $7.07 multiplied by its outstanding shares number of 20.47M. As a small-cap company, ACTU's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ACTU 6.87 -0.20(-2.83%)
Will ACTU be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACTU based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ACTU
Actuate: Elraglusib Continues To Deliver And Next Catalyst Is FDA Type B Meeting
Actuate Therapeutics files to sell 1.33M shares of common stock for holders
Actuate Therapeutics registers 1.33M shares for resale by investors
Actuate Therapeutics (ACTU) Plans to Issue 1.33 Million Shares of Common Stock
ACTU: Actuate Therapeutics Moves Towards Phase 2 Trial for Ewing Sarcoma | ACTU Stock News